With a deep commitment to SE Asia, PowerChina contributes to the forthcoming start-up of the China-Laos Railway

A report from CRIOnline: The countdown has begun for the opening of the China-Laos Railway, an emblematic project under China’s Belt and Road Initiative and a witness to the deep friendship between the two countries. To achieve the country’s overall goal of putting the high-speed railway into operation at the end of 2021, Power Construction Corporation […]

thaipr.net

8 พ.ย. 64

Menarini Receives FDA Orphan Drug Designation for SEL24/MEN1703, a first in class, dual PIM/FLT3 inhibitor for the Treatment of Acute Myeloid Leukemia

The Menarini Group announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug designation (ODD) to SEL24/MEN1703 for the treatment of Acute Myeloid Leukemia (AML). SEL24/MEN1703 is a first-in-class, orally available, dual PIM/FLT3 inhibitor, in-licensed by Menarini from Ryvu Therapeutics, and currently investigated in the DIAMOND-01 trial as a single agent for […]

thaipr.net

5 พ.ย. 64
1 794 795 796 797 798 1,105